Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.525
+0.025 (1.00%)
At close: Nov 4, 2024, 4:00 PM
2.650
+0.125 (4.95%)
After-hours: Nov 4, 2024, 6:19 PM EST

Galectin Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
15710367123128163
Upgrade
Market Cap Growth
63.70%52.89%-45.33%-3.92%-21.42%15.30%
Upgrade
Enterprise Value
2271478410998115
Upgrade
Last Close Price
2.521.661.132.072.242.86
Upgrade
PE Ratio
--2.23-1.73-3.95-5.41-7.40
Upgrade
PB Ratio
-1.71-1.70-2.0946.965.283.57
Upgrade
P/FCF Ratio
-4.29-3.11-2.16-5.05-6.21-15.00
Upgrade
P/OCF Ratio
-4.29-3.11-2.16-5.05-6.21-15.00
Upgrade
EV/EBIT Ratio
-5.13-3.86-2.20-3.61-4.16-8.54
Upgrade
EV/FCF Ratio
-6.21-4.46-2.71-4.48-4.74-10.57
Upgrade
Debt / Equity Ratio
-1.14-1.19-1.2411.110.000.00
Upgrade
Debt / FCF Ratio
-2.85-2.18-1.29-1.200.000.00
Upgrade
Quick Ratio
1.751.641.434.395.0316.84
Upgrade
Current Ratio
1.871.771.584.635.4617.10
Upgrade
Return on Equity (ROE)
----227.74%-67.25%-50.65%
Upgrade
Return on Assets (ROA)
-103.87%-96.17%-75.96%-52.81%-37.54%-29.23%
Upgrade
Return on Capital (ROIC)
-230.75%-246.50%-121.64%-67.46%-41.94%-31.98%
Upgrade
Earnings Yield
-30.55%-40.00%-57.74%-24.85%-18.35%-8.17%
Upgrade
FCF Yield
-20.84%-32.11%-46.25%-19.79%-16.11%-6.67%
Upgrade
Buyback Yield / Dilution
-3.32%-1.29%-1.48%-2.63%-9.17%-32.54%
Upgrade
Total Shareholder Return
-3.32%-1.29%-1.48%-2.63%-9.17%-32.54%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.